Bruce A Lefker Selected Research

PF-04445597

7/2014

Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce A Lefker Research Topics

Disease

1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Immune System Diseases (Immune Disorders) 01/2016
1	Infections 01/2016
1	Inflammation (Inflammations) 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Coronary Disease (Coronary Heart Disease) 07/2014
1	Carcinoma (Carcinomatosis) 07/2014
1	Obesity 04/2010
1	Phototoxic Dermatitis (Phototoxicity) 11/2008
1	Alopecia (Baldness) 11/2008
1	Osteoporosis 04/2006
1	Metabolic Bone Diseases (Osteopenia) 04/2006
1	Femoral Fractures (Femoral Fracture) 11/2003

Drug/Important Bio-Agent (IBA)

2	Anabolic AgentsIBA 04/2006 - 04/2006
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2016
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 01/2016
1	Imiquimod (Aldara)FDA LinkGeneric 01/2016
1	AntibodiesIBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	InflammasomesIBA 01/2016
1	PF-04445597IBA 07/2014
1	HDL CholesterolIBA 07/2014
1	Cholesterol Ester Transfer ProteinsIBA 07/2014
1	AldosteroneIBA 07/2014
1	AmidesIBA 04/2010
1	Proline (L-Proline)FDA Link 04/2010
1	Androgen Receptor AntagonistsIBA 11/2008
1	Dinoprostone (PGE2)FDA Link 04/2006
1	CP533536IBA 11/2003